Roche’s new Accu-Chek Instant blood glucose monitoring system – clarity at a glance and wireless data availability help make diabetes routines effortless

 No set-up required, just insert a strip, apply a small blood sample and have instant clarity with the intuitive target range indicator
 Easy-edge test strips with a wide dosing area help make blood application easy
 Automatic synchronization: all blood glucose results transferred wirelessly to a smartphone or via USB to a PC

Roche Diabetes Care announced today the launch of the new Accu-Chek Instant blood glucose monitoring system. The number one goal when creating this new meter was to provide a solution for people with diabetes that was easy to use and accurate. “We want to help people with diabetes worry less and get some relief from their daily diabetes tasks. The Accu-Chek Instant meter makes self-monitoring effortless and convenient which means less time thinking about diabetes management routines” says Adeniyi Adeola, the Product Manager, at Roche Diabetes Care Nigeria.

Simple preparation

People with diabetes want to have a blood glucose monitoring system that is easy to use and reliable, and report they would test more frequently if the procedure was easier1,2. With the Accu-Chek Instant system, checking blood glucose (BG) values is as little effort as checking phone messages. There is no need to spend time setting up the device. After inserting a test strip and applying a tiny blood drop (0.6 μL) the result is available in less than four seconds. The one button navigation eliminates scrolling through menus and the last test results and averages over the last 7/30/90 days are shown easily. Moreover, the meter can save at least 720 results and even though this is not visible on the meter, all blood glucose results are wirelessly transferred to the MySugr app on a smartphone or via USB to a PC (using the Accu-Chek SmartPix) to help the healthcare provider analyse the readings.

Instant clarity

One of the most important things for people with diabetes is to quickly understand where they stand and what they need to do next to keep their glucose levels in their individual target range. With the Accu-Chek Instant meter, the intuitive target range indicator immediately shows the range someone with diabetes is in: The arrow directly points to a colour on the right of the screen: blue for above range, green for in range and red for below range. In fact, in a comparison study, more than 90% of study participants said the target range indicator on the Accu-Chek Instant system is helpful to interpret their BG values easily and quickly3. The scale can also be personalised to suit personal therapy goals.

New test strip design

The Accu-Chek Instant system, with its new test strip chemistry delivers a level of accuracy that exceeds the current ISO 15197:2013/EN ISO 15197:2015 system accuracy requirements4,5. The easy-edge dosing area allows the placement of a small drop of blood anywhere along the wide yellow edge, which makes applying blood much easier. The strip offers a wide blood application area compared to leading brands.

Effortless synchronisation

People with diabetes do not want the hassle of logging their glucose values manually in a diary – they want automated logging and seamless availability of their diabetes-related data. The Accu-Chek Instant system offers exactly that. Once the meter is connected to the MySugr app, which can be downloaded, from the Google Playstore or the Apple App store, the app automatically logs blood glucose results. Results can be sent instantly via the app to keep caregivers informed and if necessary, data can also be shared automatically with a doctor for immediate help or to aid face-to-face or virtual consultations. This allows people with diabetes, healthcare providers or caregivers peace of mind knowing that the important diabetes information is available virtually whenever and wherever needed.

About Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry eight years in a row by the Dow Jones Sustainability Indices.
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2015 employed more than 91,700 people worldwide. In 2015, Roche invested CHF 9.3 billion in R& and posted sales of CHF 48.1 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.

About Roche Diabetes Care

Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For 40 years, the Accu-Chek brand has been dedicated to enable people with diabetes to live life as normal and active as possible as well as to empower healthcare professionals manage their patients’ condition in an optimal way. Today, the Accu-Chek portfolio offers people with diabetes and healthcare professionals innovative products and impactful solutions for convenient, efficient and effective diabetes management. It encompasses blood glucose meters, insulin delivery systems, lancing devices, data management systems and education programs – contributing to an improved medical outcome. For more information: www.accu-chek.com

For more information, please contact
Name: Adeniyi Adeola
Roche Diabetes Care, 48/50 Isaac John street, Ikeja GRA, Lagos, Nigeria
Phone: 08052596359
E-Mail: adeniyi.adeola@roche.com
or visit
www.accu-chek.com

Where can I get the stripe please